Dalteparin in Preventing Blood Clots in Patients With Lung Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Anticoagulants, such as dalteparin, may help prevent blood clots from forming in
patients with lung cancer. It is not yet known whether dalteparin is effective in preventing
blood clots in patients with lung cancer.
PURPOSE: This randomized phase III trial is studying how well dalteparin works in preventing
blood clots in patients with lung cancer.